SARAH ULLAH
Prescription History 1982947230
Ophthalmology in Danville, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SARAH ULLAH, an active Ophthalmology specialist practicing in Danville, PA. Our medical registry currently tracks 24 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,815 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 435 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Latanoprost | 435 | $17.18▼ below PA avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 435 Medicare prescriptions for Latanoprost, about 3.5 times the volume of the typical Pennsylvania prescriber of this medication (123). Medicare paid an average of $17.18 per fill, versus $18.58 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 785.7 30-Day Fills standardized to 30-day supplies 22,650 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 334 | $29.92▼ below PA avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 334 Medicare prescriptions for Dorzolamide-Timolol, about 4.4 times the volume of the typical Pennsylvania prescriber of this medication (76). Medicare paid an average of $29.92 per fill, versus $31.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 715.6 30-Day Fills standardized to 30-day supplies 21,424 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 213 | $47.19▼ below PA avg | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 213 Medicare prescriptions for Brimonidine Tartrate, about 3.9 times the volume of the typical Pennsylvania prescriber of this medication (54). Medicare paid an average of $47.19 per fill, versus $53.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 418.2 30-Day Fills standardized to 30-day supplies 12,442 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 128 | $46.92▼ below PA avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 128 Medicare prescriptions for Timolol Maleate, about 9.1 times the volume of the typical Pennsylvania prescriber of this medication (14). Medicare paid an average of $46.92 per fill, versus $467.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 281.5 30-Day Fills standardized to 30-day supplies 8,421 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 98 | $536.51 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 98 Medicare prescriptions for Lumigan, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (72). Medicare paid an average of $536.51 per fill, versus $440.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 184.5 30-Day Fills standardized to 30-day supplies 5,368 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 87 | $55.07 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 87 Medicare prescriptions for Prednisolone Acetate, about 67% of the volume of the typical Pennsylvania prescriber of this medication (130). Medicare paid an average of $55.07 per fill, versus $46.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 132.6 30-Day Fills standardized to 30-day supplies 3,669 Days of Medication total across all patients in 2023 | |||
| Travoprost | 82 | $240.66▼ below PA avg | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 82 Medicare prescriptions for Travoprost, about 2.4 times the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $240.66 per fill, versus $247.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 133.8 30-Day Fills standardized to 30-day supplies 3,789 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 67 | $475.66▼ below PA avg | ▲ More than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 67 Medicare prescriptions for Rocklatan, about 2 times the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $475.66 per fill, versus $493.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 96.8 30-Day Fills standardized to 30-day supplies 2,609 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 56 | $446.59▼ below PA avg | ≈ Typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 56 Medicare prescriptions for Rhopressa, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (45). Medicare paid an average of $446.59 per fill, versus $454.62 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 76.2 30-Day Fills standardized to 30-day supplies 2,119 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 50 | $30.54 | ≈ Typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 50 Medicare prescriptions for Dorzolamide Hcl, about the same volume as the typical Pennsylvania prescriber of this medication (46). Medicare paid an average of $30.54 per fill, versus $30.06 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 108.6 30-Day Fills standardized to 30-day supplies 3,251 Days of Medication total across all patients in 2023 | |||
| Methazolamide | 42 | $271.66▼ below PA avg | ▲ More than typical |
About Methazolamide: This medication is used to treat high pressure inside the eye due to certain types of glaucoma. Show more ▾ Lowering high pressure inside the eye helps to prevent blindness, vision loss, and nerve damage. Methazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma. In 2023, this provider wrote 42 Medicare prescriptions for Methazolamide, about 2 times the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $271.66 per fill, versus $303.05 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 43 30-Day Fills standardized to 30-day supplies 1,262 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 24 | $19.76▼ below PA avg | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 24 Medicare prescriptions for Ketorolac Tromethamine, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (98). Medicare paid an average of $19.76 per fill, versus $22.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 36.6 30-Day Fills standardized to 30-day supplies 1,039 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 22 | $482.14 | ▼ Less than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 22 Medicare prescriptions for Alphagan P, about half the volume of the typical Pennsylvania prescriber of this medication (42). Medicare paid an average of $482.14 per fill, versus $351.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38.1 30-Day Fills standardized to 30-day supplies 1,102 Days of Medication total across all patients in 2023 | |||
| Acetazolamide ErAcetazolamide | 21 | $41.88▼ below PA avg | ≈ Typical |
About Acetazolamide Er: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 21 Medicare prescriptions for Acetazolamide Er, about 84% of the volume of the typical Pennsylvania prescriber of this medication (25). Medicare paid an average of $41.88 per fill, versus $63.77 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 21 30-Day Fills standardized to 30-day supplies 506 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 19 | $163.54▼ below PA avg | ≈ Typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 19 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 79% of the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $163.54 per fill, versus $273.74 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 31.5 30-Day Fills standardized to 30-day supplies 915 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 19 | $389.51 | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 19 Medicare prescriptions for Simbrinza, about 63% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $389.51 per fill, versus $256.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.2 30-Day Fills standardized to 30-day supplies 1,006 Days of Medication total across all patients in 2023 | |||
| Atropine Sulfate | 19 | $55.56 | ≈ Typical |
About Atropine Sulfate: This medication is used before eye examinations (such as refraction) and to treat certain eye conditions (such as uveitis). Show more ▾ It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye. An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. In 2023, this provider wrote 19 Medicare prescriptions for Atropine Sulfate, about 83% of the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $55.56 per fill, versus $47.53 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.3 30-Day Fills standardized to 30-day supplies 887 Days of Medication total across all patients in 2023 | |||
| MoxifloxacinMoxifloxacin Hcl | 18 | $29.73▼ below PA avg | ▼ Less than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2023, this provider wrote 18 Medicare prescriptions for Moxifloxacin, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (85). Medicare paid an average of $29.73 per fill, versus $34.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 18 30-Day Fills standardized to 30-day supplies 340 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 18 | $365.17▼ below PA avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 18 Medicare prescriptions for Combigan, about a third of the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $365.17 per fill, versus $368.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,047 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 15 | $1,604.66 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 15 Medicare prescriptions for Restasis, about a third of the volume of the typical Pennsylvania prescriber of this medication (46). Medicare paid an average of $1,604.66 per fill, versus $1,073.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 14 | $409.63 | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 14 Medicare prescriptions for Brinzolamide, about half the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $409.63 per fill, versus $324.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.7 30-Day Fills standardized to 30-day supplies 1,190 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 12 | $409.09 | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 12 Medicare prescriptions for Vyzulta, about half the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $409.09 per fill, versus $399.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.7 30-Day Fills standardized to 30-day supplies 530 Days of Medication total across all patients in 2023 | |||
| Betoptic SBetaxolol Hcl | 11 | $386.18▼ below PA avg | ▼ Less than typical |
About Betoptic S: This medication is used alone or with other medications to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. Betaxolol belongs to a class of drugs known as beta blockers and works by decreasing the amount of fluid that is made within the eye. In 2023, this provider wrote 11 Medicare prescriptions for Betoptic S, about 73% of the volume of the typical Pennsylvania prescriber of this medication (15). Medicare paid an average of $386.18 per fill, versus $440.88 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 14.6 30-Day Fills standardized to 30-day supplies 440 Days of Medication total across all patients in 2023 | |||
| ValacyclovirValacyclovir Hcl | 11 | $87.05 | ▼ Less than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2023, this provider wrote 11 Medicare prescriptions for Valacyclovir, about half the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $87.05 per fill, versus $43.73 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 550 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for SARAH ULLAH is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Danville, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
